Originally published In Press as doi:10.1074/jbc.M201909200 on June 17, 2002
J. Biol. Chem., Vol. 277, Issue 37, 33624-33631, September 13, 2002
Regulation of the Gts1p Level by the Ubiquitination System to
Maintain Metabolic Oscillations in the Continuous Culture of Yeast*
Toshiki
Saito
,
Kazuhiro
Mitsui§,
Yoshiki
Hamada
, and
Kunio
Tsurugi§¶
From the Departments of
Orthopedics and
§ Biochemistry 2, Yamanashi Medical University, 1110 Shimokato, Tamaho, Yamanashi, 409-3898 Japan
Received for publication, February 26, 2002, and in revised form, May 24, 2002
 |
ABSTRACT |
Yeast cells exhibit sustained ultradian
oscillations of energy metabolism in coupling with cell cycle and
stress resistance oscillations in continuous culture. We have reported
that the rhythmic expression of Gts1p is important for the maintenance of ultradian rhythms. Structurally, Gts1p contains sequence motifs similar to N-degron and the ubiquitin association domain,
raising the possibility that the Gts1p level is regulated by
degradation via ubiquitination. When the lysine residue at the putative
ubiquitination site of the N-degron was substituted with arginine, both
the protein level and half-life of mutant Gts1p increased. During
continuous culture, the protein level of the mutant Gts1p was elevated
and did not fluctuate, leading to the disappearance of metabolic
oscillation within a day. Furthermore, using three Gts1ps containing
mutations in the ubiquitin association domain, we showed that the lower the binding activity of the mutant Gts1ps for polyubiquitin in vitro, the higher the protein level in vivo.
Expression of the mutant Gts1ps in the continuous culture resulted in
an increase in Gts1p and early loss of the oscillation. Therefore,
Gts1p is degraded through conjugation with ubiquitin, and the UBA
domain promoted the degradation of ubiquitinated Gts1p, causing a
fluctuation in protein level, which is required for the maintenance of
metabolic oscillations.
 |
INTRODUCTION |
In an open system using a bioreactor, yeast cells exhibit
sustained ultradian oscillations of energy metabolism in a continuous (chemostat) culture under aerobic and glucose-limited conditions (1-4). The energy metabolism pathway has been proven to be an autogenous oscillator under extreme nonequilibrium energy conditions according to the theory of "dissipative structures" established by
Prigogine and others (5-7). In brief, the metabolic pathway oscillates
autonomously under the primary control of phosphofructokinase, transferring energy from glucose to NADH, which acts as the
feed-forward activator, and then from NADH to ATP, which acts as the
feedback inhibitor. After ATP as an inhibitor is consumed as fuel for
various ATPases, glucose again begins to enter the glycolytic pathway. The oscillations are detectable as a periodic change in the factors involved in energy metabolism such as dissolved oxygen
(DO)1 levels, CO2
production, glucose and ethanol concentrations, and amounts of storage
carbohydrates. DO oscillation is due to the periodic change between
respiratory and respiro-fermentative phases in which oxygen demands are
relatively high and low, respectively. DO oscillations arise
spontaneously in concert with cell division and are dependent on a high
cell density (~5 × 108 cells/ml), regulating the
cell density throughout the oscillation (8). We have reported that
cellular responses to various stress conditions, such as heat,
oxidative agents, and cytotoxic compounds, are regulated in concert
with metabolic oscillation (8) and that the
coupling2 was disrupted by
inactivation of the GTS1 gene (9). Furthermore, we suggested
that the rhythmic expression of Gts1p is more important than protein
level for the maintenance of ultradian rhythms, since the constitutive
expression of GTS1 under the control of the TPI promoter resulted in the disappearance of ultradian rhythms (9). More
recently, we reported that, when GTS1 was expressed under the control of a short (183-bp) promoter in the
GTS1-disrupted mutant, the amplitude of Gts1p fluctuations
was restricted, leading to the attenuation of the metabolic oscillation
and to the uncoupling of stress-resistance oscillations (10). Thus, we
suggested that, in order for stress resistance oscillations to occur, a
full fluctuation in the level of Gts1p is required. Furthermore, we
found that the mRNA level of GTS1 fluctuated with a
broad peak at the respiro-fermentative phase, which is the opposite of
the Gts1p fluctuation (10), suggesting that GTS1 expression
was regulated in an oscillatory manner at the transcriptional level.
However, it is likely that the oscillatory expression of
GTS1 is not sufficient to cause a fluctuation in the protein
level, since the protein needs to be degraded for any subsequent
increase to occur and/or for regulation of the protein level.
In this paper, we examined whether the fluctuation in the level of
Gts1p is controlled by the ubiquitin-proteasome system, since we found
that Gts1p contains a putative N-degron (11) and ubiquitin association
(UBA) domain (12). Using site-directed mutagenesis at the sequence
motifs, we examined the effects of mutations on the fluctuation in
Gts1p expression and the oscillations in energy metabolism during
continuous culture. The results suggested that the fluctuation in the
level of Gts1p is regulated by the ubiquitination system in order to
maintain the oscillations of energy metabolism, in combination with the
oscillatory GTS1 expression at the transcriptional level.
 |
EXPERIMENTAL PROCEDURES |
Yeast Strains and Media--
The haploid strain
S288C (MAT
mal gal2 SUC2) of
Saccharomyces cerevisiae was used. FL599
(ise1
) (13) was a gift from Dr. J. Nittis
(Harvard University). In the batch cultures, cells were incubated at
30 °C in a synthetic medium consisting of a yeast nitrogen base
without amino acids (Difco) containing 2% glucose with the
required amino acids and bases.
Conditions for Continuous Culture--
The cells were cultured
at 30 °C, pH 5.5, in a synthetic medium containing 1% glucose as
defined elsewhere (2) using an improved bench top fermenter, MDL-6C
(Marubishi Bioengineering, Tokyo), at a constant volume of 500 ml (8).
Continuous cultures were performed at a dilution rate of 0.1 h
1 with aeration at 1 liter/h and stirring at 420 rpm.
The periodic change in respiro-fermentative metabolism was monitored by
measuring the level of DO with an oxygen electrode.
Construction of Mutant GTS1--
To obtain the wild type
GTS1, a 2.30-kilobase pair XhoI-SpeI
fragment containing both GTS1 and a 1.0-kilobase pair
upstream region was obtained by PCR directed against genomic DNA using oligonucleotides GTS-Xho and GTS-3'DS (Table I and Fig. 1A)
as 5'- and 3'-primers, respectively, and inserted into the multicloning site of the centromere-based vector pRSA103, which is derived from
pRS413 (Stratagene, La Jolla, CA) containing AUR1 from
pAUR112 (Takara, Tokyo) in place of HIS3 (9). The
XbaI site in the multicloning site of the recombinant
plasmid was removed by deletion of the SacI-SpeI
fragment to obtain pRSA-GTS1.
For construction of GTS1[K17R] encoding Gts1p(K17R)
containing a substitution at position 17 (arginine for lysine), a
PCR-amplified fragment obtained using GTS-Nhe and K17R-2 as 5'- and
3'-primer (Table I), respectively, was
ligated with a fragment obtained using K17R-1 and GTS-Spe (Table I) as
primers, after digestion with AflIII. The PCR product
amplified on the ligated fragment using GTS-Xho and GTS-Spe (Table I)
as 5'- and 3'-primers, respectively, was digested with XhoI
and XbaI and inserted into the cognate sites of
pRSA-GTS1 to obtain pRSA-GTS1[K17R]. The
mutation in pRSA-GTS1[K17R] was confirmed by sequencing
the GTS1 site in the recombinant plasmid and incorporated
into the GTS1-disrupted strain gts1
(8,
9).
To construct GTS1[TGF] encoding a substitution in MGF
between amino acids 205 and 207 of Gts1p, a fragment amplified using TGF and GTS-3'Sal as 5'- and 3'-primer (Table I), respectively, was
ligated with a fragment amplified using GTS-5'RI and GTS-3'Sal as
primers, after digestion with BsrI and SalI,
respectively. The EcoRI-SalI segment from the
ligated fragment was inserted into the cognate sites of pYX222
(Takara), and the BglII-XbaI fragment obtained
from the recombinant plasmid was inserted into the cognate sites of
pRSA-GTS1, to obtain pRSA-GTS1[TGF]. Similarly, constructs GTS1[MAQ] and GTS1[MGQ] were
obtained using oligonucleotides MAQ and MGQ as 5'-primers (Table I),
respectively, and inserted into pXY222 to give the recombinant plasmids
pRSA-GTS1[MAQ] and pRSA-GTS1[MGQ]. After
confirmation of the mutations in the mutant GTS1 genes in
the recombinant plasmids, the transformation of gts1
cells proceeded.
Treatment with a Proteasome Inhibitor and Western
Blotting--
FL599 (ise1
) was cultured until
the A600 value reached 1.0 and mixed with
MG132 at a final concentration of 50 µM. After incubation for a specific period, cells were harvested, and the protein levels of
Gts1p and actin in the cell lysates were determined by Western blotting
as described previously (9). The relative protein level of Gts1p to
actin was determined with a lumino-image analyzer (LAS1000; Fuji Film, Tokyo).
Determination of mRNA Levels by Northern
Blotting--
Northern blotting of GTS1 and
GTS1[K17R] mRNAs was performed using as probes
digoxygenin-labeled PCR products amplified with the DIG labeling
kit (Roche Molecular Biochemicals) using GTS-5'RI and GTS-3'Kpn (Table
I) as 5'- and 3'-primers, respectively. Actin mRNA was detected
using the digoxygenin-labeled PCR product as probe, which was amplified
using Actin-N and Actin-C (Table I) for 5'- and 3'-primers,
respectively. The relative mRNA level of GTS1 to actin
was determined with the lumino-image analyzer
Detection of the Gts1p-Ubiquitin Conjugate--
The
EcoRI-HindIII fragment containing the open
reading frame of GTS1 without the stop codon was amplified
on genomic DNA using GTS-5'RI and GTS-3'Hind as 5'- and 3'-primer,
respectively, and inserted into the cognate sites of pYX222 containing
the sequence of hemagglutinin (HA) epitope in a multicloning site (R&D
Systems, Minneapolis, MN). pYXHA-GTS1 carrying a fusion gene
construct encoding Gts1p tagged with HA epitope at the C terminus was
incorporated into gts1
. The transformed cells were
harvested when the A600 of the culture reached
1.0 and cell lysate was prepared by shaking with glass beads in
radioimmune precipitation buffer (9). The cell lysate was mixed with
Pansorbin (Calbiochem) and anti-HA antibody (Cell Signaling Technology,
Berkeley, CA), and the immunoprecipitate was subjected to Western
blotting using anti-ubiquitin antibody (Biogenesis, Poole, UK).
The Yeast Two-hybrid System--
The two-hybrid analysis was
performed using a Matchmaker two-hybrid system
(CLONTECH, Palo Alto, CA) as described previously (14). The open reading frame of UBI4 encoding five ubiquitin proteins in a head-to-tail arrangement (15) was amplified on genomic
DNA using UBI-5'RI and UBI-3'Sal (Table I) as 5'- and 3'-primer,
respectively, and the EcoRI-SalI fragment from
the PCR product was inserted into the cognate sites of pGAD424 in-frame with the gene encoding the activation domain of GAL4. On the
other hand, the open reading frames of wild type and mutant
GTS1 genes were amplified in the recombinant plasmid pRSA103
using GTS-5'RI and GTS-3'Sal (Table I) as 5'- and 3'-primer,
respectively. The EcoRI-SalI fragments obtained
from the PCR products were inserted into the cognate sites of pGTB9
in-frame with the gene encoding the DNA-binding domain of
GAL4. The interactions between the prey and bait hybrid
proteins were determined for the activation of the lacZ
reporter gene by measuring the
-galactosidase activity of the cells
using the liquid culture assay (14).
 |
RESULTS |
Ubiquitin-related Amino Acid Sequences in Gts1p and the Effect of a
Proteasome Inhibitor on the Gts1p Level--
Gts1p contains two
sequences homologous to ubiquitin-related motifs, N-degron and the UBA
domain (Fig. 1). If the first methionine residue is removed from Gts1p in vivo, arginine, one of the
destabilizing residues, is located at the N terminus and the
ubiquitin-binding residue lysine occupies position 17. In addition,
basic residues are present at positions 3 and 10, which have been
reported to increase the efficiency of N-degron (16). Thus, the
N-terminal sequence of Gts1p almost completely fits the consensus
sequence of N-degron if the first methionine residue is removed. On the other hand, the UBA domain consists of about 40 amino acid residues comprising three
-helices linked by two loops (12, 17). The putative
UBA domain in Gts1p has 80% homology to the consensus sequence
including three well conserved amino acid residues (Gly-206, Leu-217,
and Ala-227) (Fig. 1B). The presence of these sequences would suggest that Gts1p is degraded by the ubiquitin-proteasome system. To test this possibility, the effect of the proteasome-specific inhibitor MG132 on the degradation of Gts1p was examined using FL599
(ise1
) cells having enhanced permeability to
the drug (13). Western blotting analysis after the treatment with MG132
in vivo showed that the Gts1p level had increased by more
than 4-fold 4 h after the treatment with the drug (Fig.
2), suggesting the involvement of
proteasomes in the degradation of Gts1p.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Physical map of GTS1 and two
amino acid sequences homologous to ubiquitin-related motifs in
Gts1p. A, physical map of GTS1 indicating
approximate positions of the primers used in this study.
Vertically striped box, position of
N-degron; horizontally striped box,
UBA domain. B, amino acid sequences in Gts1p having homology
to N-degron and the UBA domain. The consensus sequence of the UBA
domain is shown as described by Suyama et al. (17) with a
slight modification according to the list shown by Hofmann and Bucher
(12). h, hydrophobic; l, aliphatic; p,
polar; s (ACDGNPSTV), small; t (ACDEGHKNQRST),
turnlike; u (AGS), tiny. Well conserved amino acids are
indicated in capital letters. Amino acid residues
in the Gts1p sequence fitting the consensus sequence are indicated in
boldface type.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of the proteasome inhibitor MG132 on
the Gts1p level. A, Western blot of Gts1p and actin in
the cell lysates from FL599 (ise1 ) cells
treated with MG132 at 50 µM for 0, 2, 4, and 8 h. In
the first lane, pure Gts1p was run as a control.
B, time course of the relative level of Gts1p to actin
determined after quantification of the Western blot in A
with a lumino-image analyzer. These are representative patterns of
three independent experiments.
|
|
Association of Gts1p with Ubiquitin--
To investigate whether
Gts1p binds ubiquitin in vivo, we first tried to detect
ubiquitin-Gts1p conjugates in the wild type cells but could not detect
any signals by Western blotting using anti-ubiquitin antibody in the
immunoprecipitate with anti-Gts1p antibody (data not shown). Then we
constructed a mutant overexpressing HA-tagged Gts1p (HA-Gts1p), named
TMpHA-GTS1, since we thought that Gts1p-ubiquitin conjugates might be
minor components. Western blot analysis of the cell lysate from
TMpHA-GTS1 using anti-Gts1p showed that there are several signals in
addition to the one corresponding to HA-Gts1p at 45 kDa (Fig.
3A). Although the additional
signals could not be found in the Western blot of cell lysate from the wild type cell, we thought that they are possibly some modified forms of Gts1p, since none of them was found in the cell lysate from
gts1
(Fig. 3A).

View larger version (65K):
[in this window]
[in a new window]
|
Fig. 3.
Detection of Gts1p-ubiquitin conjugates in
the cell lysate of yeast. A, Western blot of cell
lysates of yeast using anti-Gts1p antibody. First
lane, pure Gts1p as a control; second
lane, 10 µg of proteins from gts1 ;
third lane, 10 µg of proteins from the mutant
overexpressing HA-tagged Gts1p (TMpHA-GTS1); fourth
lane, 20 µg of proteins from the wild type cell.
B, detection of Gts1p-ubiquitin conjugates in cell lysate of
TMpHA-GTS1 by Western blotting. Left lane,
Western blot of cell lysate of yeast overexpressing HA-Gts1p detected
using anti-Gts1p antibody as a control; right
lane, Western blot of the immunoprecipitate with anti-HA
antibody detected using anti-ubiquitin antibody. The protein samples
were electrophoresed in a gel, and, after the electrophoresis, the gel
was cut between the left and right
lanes. The arrowhead and arrow
indicate the positions of HA-Gts1p and the major ubiquitin-Gts1p
conjugate, respectively. These are representative patterns of three
independent experiments.
|
|
To detect Gts1p-ubiquitin conjugates in TMpHA-GTS1, the cell lysate was
immunoprecipitated with anti-HA antibody, and Gts1p-ubiquitin conjugates were detected in the immunoprecipitate by Western blotting using anti-ubiquitin antibody (Fig. 3B). A major signal
suggestive of Gts1p-ubiquitin conjugates had a molecular mass of 55 kDa, which corresponds approximately to that of HA-tagged Gts1p (45.6 kDa) conjugated with one molecule of ubiquitin (8.5 kDa) (Fig. 3B, right lane). Since there is no
band at the position corresponding to the 55-kDa signal in the Western
blot of the original lysate obtained using anti-Gts1p antibody (Fig.
3B, left lane), the 55-kDa conjugate
is thought to be a minor component in the Gts1p population. In
addition, none of the signals found in the Western blot of the lysate (Fig. 3, left lane) turned out to be a
ubiquitin conjugate. At present, we do not know the nature of these
signals. It should be pointed out that there are some minor bands
stained like a smear in the high molecular weight region above the
major band. Thus, the results suggested that Gts1p is conjugated with
ubiquitin in a predominantly monoubiquitinated form.
Effect of Mutation at the Putative Ubiquitin Ligation Site of
N-degron of Gts1p on the Metabolic Oscillation--
To examine whether
the N-degron of Gts1p is involved in its degradation, a mutant
Gts1p(K17R) containing arginine at position 17 instead of lysine was
expressed in the GTS1-disrupted mutant, gts1
, and the
level of Gts1p(K17R) was determined (Fig.
4). The level was 2.4-fold that of the
wild type protein, whereas the mRNA level was slightly decreased
(0.8-fold), suggesting that the mutant Gts1p accumulated due to some
deficiency at the step after transcription (Fig. 4). The half-lives of
Gts1p and Gts1p(K17R) were then compared after the inhibition of
protein synthesis with cycloheximide (Fig.
5). The results showed that the half-life of Gts1p(K17R) was about 12 h, which is ~4 times longer than
that of the wild type Gts1p (3.5 h), suggesting that Gts1p(K17R) was accumulated due to a defect in degradation. Thus, the N-degron of Gts1p
is probably involved in the degradation of Gts1p.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Effect of mutation at the putative ubiquitin
ligation site of N-degron of Gts1p on the intracellular levels of Gts1p
and GTS1 mRNA. The levels of Gts1p
(A) and GTS1 mRNA (B) in the wild
type cell (WT) and gts1 cells transformed with
GTS1[K17R] (K17R) were determined by Western and Northern
blotting, respectively. The relative levels of Gts1p and
GTS1 mRNA to actin and actin mRNA, respectively, in
GTS1[K17R]-transformed gts1 cells were
calculated to be 2.37- and 0.78-fold those in the wild type cell,
respectively, after quantification with the lumino-image analyzer.
These are representative patterns of two independent experiments.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 5.
Effect of mutation at the putative
ubiquitin-ligation site of N-degron of Gts1p on its own degradation
rate. Time courses of the protein levels of Gts1p (A)
and Gts1p(K17R) (B) relative to actin were determined by
Western blotting after the treatment with cycloheximide. Cells were
treated with 50 µg/ml cycloheximide and incubated for specified
periods. Half-lives of Gts1p and Gts1p(K17R) were estimated to be 3.5 and about 12 h, respectively.
|
|
We examined the effect of the K17R mutation in Gts1p on the maintenance
of the energy-metabolism oscillation monitored by measuring the
concentration of DO in continuous culture (Fig. 6). As we previously reported (9), the
wild type Gts1p, expressed with the centromeric recombinant plasmid
carrying GTS1[N-C] with its upstream region of about 1.0 kilobase pair rescued the metabolic oscillations lost in
gts1
(Fig. 6A). The energy metabolism
oscillation continued for about 4 days, although the amplitude of DO
oscillation was about 30% lower than it was in the wild type cell
(Table II). The Gts1p level
oscillated at a level nearly identical to that of the wild type cell
(data not shown) as reported previously (9). In contrast,
the oscillation in gts1
cells expressing Gts1p(K17R) ceased within a day (Fig. 6B). The Gts1p(K17R) level was
twice the peak value of Gts1p in the wild type cells during the
transient DO oscillation (Fig. 6B). The
fluctuation in the level of Gts1p(K17R) was severely restricted
(Fig. 6C) compared with that of the wild type Gts1p
expressed in either the wild type or gts1
cells
transformed with GTS1 (9) (Table II). In addition, the
amplitude of the cell cycle oscillation also decreased. These results
suggest that the N-degron of Gts1p is involved in the degradation of
protein necessary for the fluctuation at the protein level and support the notion that periodic change in the Gts1p level is
necessary for the persistent DO oscillation during the continuous
culture.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 6.
Effect of mutation at the putative
ubiquitin-ligation site of N-degron of Gts1p on the oscillation of the
energy metabolism. A, the DO oscillation in
gts1 expressing the wild type Gts1p with the centromeric
recombinant plasmid carrying pRSA-GTS1 with its upstream
region of about 1.0 kilobase pair. B, the DO oscillation
in gts1 cells expressing Gts1p(K17R) with the plasmid
pRSA-GTS1[K17R]. The horizontal bar
indicates the time when cell samples for C were collected.
C, the fluctuation of the Gts1p level during the DO
oscillation in gts1 cells expressing Gts1p(K17R). The
open square in the column
marked WT indicates the relative Gts1p level at
the maximum of the fluctuation during the DO oscillation in the wild
type cell as a control. The broken line indicates
a schematic diagram showing the fluctuation of the Gts1p level in
A superimposed over the OD oscillation as a comparison (the
patterns of Western blotting were shown in Ref. 9). These are
representative patterns of three independent experiments.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
The fluctuation in Gts1p level and oscillation in DO concentration in
the wild type and gts1 transformed with the wild type and mutant
Gts1ps
|
|
The Binding Activity of the UBA Domain of Gts1p for
Ubiquitin--
The UBA domain has been identified in various classes
of proteins including those in the ubiquitin-proteasome system (12). The function of the domain has not been elucidated, although it was
reported that the UBA domains of Rad23p and Ddi1p, DNA-damage-inducible proteins, bind to ubiquitin noncovalently in the yeast two-hybrid system (18). We investigated whether the UBA domain of Gts1p can
associate with ubiquitin using the yeast two-hybrid system. When the
monoubiquitin gene, which was amplified by polymerase chain reaction
from UBI4 encoding five ubiquitin genes in tandem (15), was
used as a bait in the system, Gts1p as prey did not bind to the protein
(data not shown). However, when the whole UBI4 gene was used
as bait, Gts1p did bind to the polyubiquitin protein, although the
binding activity as determined using
-galactosidase was about half
that of Gts1p proteins (14) (Table
III). To further determine the
binding activity of Gts1p to ubiquitin via the UBA domain, we
introduced site-directed mutations in the amino acid triplet MGF
between positions 205 and 207, since G-206 is the one of the most
conserved residues among UBA sequences (12) (Fig. 1). We constructed
four mutant Gts1ps containing TGF, MAF, MGQ, and MAQ in place of MGF,
named Gts1p(TGF), and so on. However, since gts1
expressing Gts1p(MAF) grew very slowly, it could not be used in further
experiments. We do not know the reason why gts1
expressing Gts1p(MAQ), which contains another mutation at F-207, grew
fairly well, but it should be pointed out that MAF is more hydrophobic
than the wild type MGF, whereas MAQ retains some hydrophilicity similar
to that of MGF. Of the three mutant Gts1ps tested, Gts1p(MAQ) was
reduced most in terms of the activity to bind ubiquitin followed by
that of Gts1p(TGF) (Table III). Since the binding activity of
Gts1p(MGQ) to ubiquitin did not change as much as that of the wild
type, Gly-206 is the most important residue for binding in the three
mutant Gts1ps, which is consistent with the fact that Gly-206 is well
conserved among UBA sequences. Thus, it is likely that the UBA domain
of Gts1p can associate with ubiquitin, as shown in a previous
report (18).
Effect of Mutations in the UBA Domain of Gts1p on Its
Degradation--
To examine whether the UBA domain is involved in the
degradation of Gts1p itself, the protein levels of the mutant Gts1ps were measured (Fig. 7). Among the three
mutant Gts1ps, the protein level of Gts1p(MAQ) was increased the most,
followed by that of Gts1p(TGF) (Fig. 7). This was the reverse of the
case for the binding activity for polyubiquitin (Table III), showing
that the lower the binding activity for polyubiquitin, the lower the
degradation capacity of the protein itself.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 7.
The protein levels of the wild type and
mutant Gts1ps containing an amino acid substitution in the UBA
domain. gts1 cells were transformed with
recombinant plasmids carrying GTS1[TGF],
GTS1[MAQ], and GTS1[MGQ], and relative levels
of Gts1p to actin were determined by Western blotting. WT
indicates the relative Gts1p level in the wild type cell. The Gts1p
levels among the cells were compared by assigning the relative protein
level in the wild type a value of 1. These are representative patterns
of three independent experiments.
|
|
Effect of Mutations in the UBA Domain of Gts1p on the Metabolic
Oscillation--
When Gts1p(MAQ), whose activity to bind ubiquitin was
most affected among the three, was expressed in gts1
in
continuous culture, no oscillation in the concentration of DO was seen
(Fig. 8). The Gts1p level was about twice
the peak value in the wild type cells and seemed to gradually increase
(Fig. 8 and Table II). On the other hand, gts1
cells
expressing Gts1p(TGF) whose activity to bind ubiquitin is intermediate
among the three showed a transient DO oscillation, which disappeared
within a day (Fig. 9A and
Table II). The Gts1p(TGF) level during this transient oscillation did
not fluctuate and remained equivalent to the peak value of Gts1p (Fig.
9B). In contrast, gts1
cells expressing
Gts1p(TGQ) exhibited a metabolic oscillation with a high amplitude
similar to that of the wild type cell (Table II). However,
the oscillation did not last as long (~3 days) (data not shown),
probably because the amplitude of the Gts1p(TGF) level was
significantly restricted, although the protein level was similar to
that of the wild type cell (Table II). These results suggested that the
UBA domain of Gts1p is involved in the degradation of the protein to
regulate the fluctuation in the protein level, which is in turn
required to maintain the oscillation of energy metabolism.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 8.
The DO oscillation and the Gts1p level during
continuous culture in gts1 cells
expressing Gts1p(MAQ). In the box, open
circles indicate relative levels of Gts1p to actin at
defined times, and a filled circle (wild type
(WT)) indicates the relative Gts1p level at the maximum of
the fluctuation during the DO oscillation in the wild type cells as a
control. These are representative patterns of two independent
experiments.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 9.
Effect of mutation in the UBA domain of Gts1p
(Gts1p(TGF)) on the metabolic oscillation. A, the DO
oscillation in gts1 cells expressing Gts1p(TGF) in
continuous culture. The horizontal bar indicates
the time when cell samples for B were collected.
B, the fluctuation of the Gts1p level during the DO
oscillation in gts1 cells expressing Gts1p(TGF).
Open circles indicate relative levels of Gts1p to
actin, and the filled circle in the WT
column indicates the relative Gts1p level at the maximum of
the fluctuation during the DO oscillation in the wild type cells as a
control. These are representative patterns of three independent
experiments.
|
|
 |
DISCUSSION |
In this report, we suggested that Gts1p was degraded via the
ubiquitin-proteasome system through ubiquitination at K-17, although it
is not clear whether the first methionine, one of the stabilizing residues according to the N-end rule (11), is removed. In fact, we
previously sequenced the N-terminal portion of Gts1p isolated from
yeast overexpressing the protein under the control of the TPI promoter in a multicopy vector and found that this
protein, if not all proteins, contained the first
methionine.3 However, the
result does not eliminate the possibility that the overexpressed Gts1p
partly evades excision of the first methionine. The results of the
present study showing that Gts1p had a half-life of 3.5 h in the
wild type cells after cycloheximide treatment suggested that Gts1p has
a destabilizing residue at the N terminus, taking into consideration
that inhibition of protein synthesis with cycloheximide generally
promotes the stabilization of proteins and mRNAs. Furthermore, the
K17R mutation resulted in an increase in the level of Gts1p and a
longer half-life, suggesting ubiquitination at Lys-17. In addition, we
detected a Gts1p-ubiquitin conjugate in cell lysate, although it was of
a monoubiquitinated form. This result is in contrast to other reports
(19, 20), where overexpressed Myc and x-ray-induced p53 formed
multiubiquitin conjugates in a ladder-like fashion. Monoubiquitination
has been reported to target membrane-bound proteins for endocytosis,
leading to eventual degradation in vacuoles (21, 22). However, it is
unlikely that Gts1p is degraded in vacuoles, since the protein is
located in the supernatant of the cell lysate and the degradation is
inhibited by the proteasome inhibitor MG132. It is possible that the
Gts1p associated with multiubiquitin chains undergoes rapid degradation.
We showed that the UBA domain of Gts1p is involved in the interaction
with ubiquitin using the two-hybrid assay and that the domain promoted
the degradation of Gts1p itself. The result of the assay is consistent
with the report by Bertolaet et al. (18) in which the UBA
domains of Rad23p and Ddi1p bind ubiquitin noncovalently. The result
showing that Gts1p did not bind to the ubiquitin monomer in the
two-hybrid system is in close agreement with a recent report (23) that
indicates that UBA domain-containing proteins like Rad23 and Mud1 bind
more than 300 times more tightly to polyubiquitin than to
monoubiquitin. The binding of the polyubiquitin of the three mutant
Gts1ps at the UBA domain in vitro decreased in parallel with
the capacity for degradation of Gts1p in vivo. Gts1p(MAQ) containing a Gly to Ala substitution at position 206, which most affected the association with polyubiquitin, was most deficient in the
degradation of Gts1p. The Gly residue is one of the most conserved in
the UBA domain and is located in the loop linking
-helices 1 and 2 and is known to comprise a part of the hydrophobic surface to which the
ubiquitin molecule is thought to bind (18, 24). The result suggested
that the UBA domain is involved in the degradation of
multiubiquitinated Gts1p in an autoregulated (autocatalytic) manner,
since the expression of Gts1p(MAQ) which contains an intact
N-degron resulted in the complete loss of the fluctuation of
Gts1p level in the continuous culture. This may be a reason why
multiubiquitinated Gts1p was not detected in cell lysate by Western
blotting. However, since this domain is contained in many proteins
without N-degron and reportedly interacts with proteins other than
ubiquitin (24), the possibility remains that it has as yet unknown
functions in addition to the degradation of Gts1p itself.
In this report, we presented evidence that the degradation of Gts1p by
the ubiquitin-proteasome system is necessary for a rhythmic expression
of the protein. It now remains to be elucidated when and how the
ubiquitination system is activated during metabolic oscillation in a
continuous culture. Since the ubiquitin-proteasome system requires a
large amount of ATP, it is assumed that the system is activated in the
respiratory phase when much more ATP is produced in mitochondria than
in the respiro-fermentative phase when glycolysis is predominant.
Consistently, the decrease of Gts1p begins in the middle of the
respiratory phase (9, 10). However, since the expression of
GTS1 is regulated in an oscillatory manner at the
transcription level (10), the regulation at the rhythmic expression of
Gts1p may be much more complicated than anticipated here.
It would be interesting to note that the ubiquitin-proteasome system is
involved in the regulation of biological rhythm in higher organisms.
The three clock-related PAS proteins from Arabidopsis contain the F-box characteristic of proteins that direct
ubiquitin-mediated degradation (25, 26), and in Drosophila a
clock-related protein called timeless (TIM) is known to be degraded by
the ubiquitin-proteasome system in response to light (27). These and
our results suggested the involvement of the ubiquitin-proteasome
system in the regulation of biological rhythms.
In this report, we showed, for the first time, that the
ubiquitin-proteasome system is involved in the regulation of the
ultradian oscillation of the energy metabolism by means of degrading
Gts1p in yeast. These results are very important and suggest for
further study on the molecular mechanism of how ultradian
rhythms in yeast are regulated. Furthermore, since the energy
metabolism pathway has been proven to be an autogenous oscillator in
dissipative structures including all living organisms, these data will
contribute to studies on the biological rhythms in other organisms.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel./Fax:
55-273-6784; E-mail: ktsurugi@res.yamanashi-med.ac.jp.
Published, JBC Papers in Press, June 17, 2002, DOI 10.1074/jbc.M201909200
2
In this report, the term "coupling" is used
to refer to a state in which multiple oscillators fluctuate with the
same periodicity irrespective of phase.
3
S. Yaguchi and K. Tsurugi, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
DO, dissolved
oxygen;
UBA, ubiquitin association;
HA, hemagglutinin.
 |
REFERENCES |
| 1.
|
Parulekar, S. J.,
Semones, G. B.,
Rolf, M. J.,
Lievense, J. C.,
and Lim, H. C.
(1986)
Biotechnol. Bioeng.
28,
700-710[Medline]
[Order article via Infotrieve]
|
| 2.
|
Porro, D.,
Martegani, E.,
Ranzi, B. M.,
and Alberghina, L.
(1988)
Biotechnol. Bioeng.
32,
411-417[Medline]
[Order article via Infotrieve]
|
| 3.
|
Strässle, C.,
Sonnleitner, B.,
and Fiechter, A.
(1988)
J. Biotechnol.
7,
299-318
|
| 4.
|
Chen, C. I.,
and McDonald, K. A.
(1990)
Biotechnol. Bioeng.
36,
28-38[Medline]
[Order article via Infotrieve]
|
| 5.
|
Prigogine, I.,
Lefever, R.,
Goldbeter, A.,
and Herschkowitz-Kaufman, M.
(1969)
Nature
223,
913-916[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Goldbeter, A.
(1996)
Biochemical Oscillations and Cellular Rhythms
, pp. 31-88, Cambridge University Press, Cambridge, MA
|
| 7.
|
Nicolis, G.,
and Prigogine, I.
(1977)
Self-organization in Nonequilibrium Systems: From Dissipative Structures to Order through Fluctuations
, pp. 334-354, John Wiley & Sons, Inc., New York
|
| 8.
|
Wang, J.,
Liu, W.,
Uno, T.,
Tonozuka, H.,
Mitsui, K.,
and Tsurugi, K.
(2000)
FEMS Microbiol. Lett.
189,
9-13[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Wang, J.,
Liu, W.,
Mitsui, K.,
and Tsurugi, K.
(2001)
FEBS Lett.
489,
81-86[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Tonozuka, H.,
Wang, J.,
Mitsui, K.,
Saito, T.,
Hamada, Y.,
and Tsurugi, K.
(2001)
J. Biochem. (Tokyo)
130,
589-595[Abstract/Free Full Text]
|
| 11.
|
Varshavsky, A.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
12142-12149[Abstract/Free Full Text]
|
| 12.
|
Hofmann, K.,
and Bucher, P.
(1996)
Trends Biol. Sci.
21,
172-173
|
| 13.
|
Lee, D. H.,
and Goldberg, A. L.
(1996)
J. Biol. Chem.
271,
27280-27284[Abstract/Free Full Text]
|
| 14.
|
Kawabata, K.,
Mitsui, K.,
Uno, T.,
Tamura, K.,
and Tsurugi, K.
(1999)
Eur. J. Biochem.
259,
112-119[Medline]
[Order article via Infotrieve]
|
| 15.
|
Finley, D.,
Ozkaynak, E.,
and Varshavsky, A.
(1987)
Cell
48,
1035-1046[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Suzuki, T.,
and Varshavsky, A.
(1999)
EMBO J.
18,
6017-6026[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Suyama, M.,
Doerks, T.,
Braun, I. C.,
Sattler, M.,
Izaurralde, E.,
and Bork, P.
(2000)
EMBO Rep.
1,
53-58[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Bertolaet, B. L.,
Clarke, D. J.,
Wolff, M.,
Watson, M. H.,
Henze, M.,
Divita, G.,
and Reed, S. I.
(2001)
Nat. Struct. Biol.
8,
417-422[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Ellison, M. J.,
and Hochstrasser, M.
(1991)
J. Biol. Chem.
266,
21150-21157[Abstract/Free Full Text]
|
| 20.
|
Maki, C. G.,
Huibregtse, J. M.,
and Howley, P. M.
(1996)
Cancer Res.
56,
2649-2654[Abstract/Free Full Text]
|
| 21.
|
Terrell, J.,
Shin, S.,
Dunn, R.,
and Hicke, L.
(1998)
Mol. Cell
1,
193-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Lucero, P.,
Penalver, E.,
Vela, L.,
and Lagunas, R.
(2000)
J. Bacteriol.
182,
241-243[Abstract/Free Full Text]
|
| 23.
|
Wilkinson, C. R. M.,
Seeger, M.,
Hartmann-Petersen, R.,
Stone, M.,
Wallace, M.,
Semple, C.,
and Gordon, C.
(2001)
Nat. Cell Biol.
3,
939-943[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Dieckmann, T.,
Withers-Ward, E. S.,
Jarosinski, M. A.,
Liu, C. F.,
Chen, I. S. Y.,
and Feigon, J.
(1998)
Nat. Struct. Biol.
5,
1042-1047[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Somers, D. E.,
Schultz, T. F.,
Milnamow, M.,
and Kay, S. A.
(2000)
Cell
101,
319-329[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Nelson, D. C.,
Lasswell, J.,
Rogg, L. E.,
Cohen, M. A.,
and Bartel, B.
(2000)
Cell
101,
331-340[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Naidoo, N.,
Song, W.,
Hunter-Ensor, M.,
and Sehgal, A.
(1999)
Science
285,
1737-1741[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Yerlikaya and B. A. Stanley
S-Adenosylmethionine Decarboxylase Degradation by the 26 S Proteasome Is Accelerated by Substrate-mediated Transamination
J. Biol. Chem.,
March 26, 2004;
279(13):
12469 - 12478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-i. Yaguchi and K. Tsurugi
Gts1p Activates SNF1-dependent Derepression of HSP104 and TPS1 in the Stationary Phase of Yeast Growth
J. Biol. Chem.,
August 8, 2003;
278(32):
29760 - 29768.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.